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Recent studies have begun to elucidate how the endothelial lineage is specified from the nascent
mesoderm [1,2]; however, the molecular mechanisms which regulate this process remain
largely unknown. We hypothesized that Notch signaling might play an important role in
specifying endothelial progenitors from the mesoderm, since this pathway acts as a bipotential
cell fate switch on equipotent progenitor populations in other settings [3,4]. We found that
zebrafish embryos with decreased levels of Notch signaling exhibited a significant increase in
the number of endothelial cells, while embryos with increased levels of Notch signaling
displayed a reduced number of endothelial cells. Interestingly, there was a concomitant gain
of endothelial cells and loss of erythrocytes in embryos with decreased Notch activity, without
a significant effect on cell proliferation or apoptosis. Lineage tracing analyses indicate that the
ectopic endothelial cells in embryos with decreased Notch activity originate from mesodermal
cells that normally produce erythrocytes. Taken together, these data suggest that Notch
signaling negatively regulates the number of endothelial cells by limiting the number of
endothelial progenitors within the mesoderm, possibly functioning as a cell fate switch between
the endothelial and the hematopoietic lineages.
Results and Discussion
In order to determine the function of Notch signaling during the specification of the endothelial
lineage, we first evaluated the effects of decreased Notch activity on endothelial cells at early
stages of zebrafish development. Tg(kdrl:EGFP)s843 [5] embryos were treated with 100μM
DAPT (in 5% DMSO), a known chemical antagonist of Notch signaling [6], or 5% DMSO
(vehicle alone) from 6 to 18 hours post-fertilization (hpf), and the number of endothelial nuclei
within a single transverse section of each embryo was quantified. At the 10th somite level, an
average of 6.66 (s=2.42) endothelial nuclei was present in embryos treated with DAPT (n=44),
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compared to an average of 4.03 (s=1.27) endothelial nuclei in control embryos treated with
DMSO (n=30), representing a 65% increase (ANOVA, p<10−6) (Fig. 1). Analysis at the 5th
somite level yielded similar results (ANOVA, p<10−5;Suppl. Fig. 1). The observed increase
in the number of GFP-positive endothelial cells in DAPT-treated embryos does not appear to
be a transgene-dependent phenomenon since similar increases were observed in other
transgenic lines, such as Tg(fli1a:nGFP)y7 [7] and Tg(kdrl:Ras-mCherry)s896 [8], that have
labeled endothelial cells (data not shown). In addition, a significant increase in the number of
endothelial cells was also observed in homozygous mindbomb (mibta56b) mutant embryos,
which lack an E3 ubiquitin ligase required for the activation of Notch by Delta [9] (Suppl. Fig.
2).
We utilized fluorescence activated cell sorting (FACS) to better quantify the effect of DAPT
treatment on the entire endothelial population. To minimize interference from the GFP
expression in the pharyngeal endoderm of the Tg(kdrl:EGFP)s843 embryos [5], casanovas4
(cass4) mutant embryos [10] were used. Previous studies have shown that the cass4 mutant
embryos completely lack endoderm, with little effect on hematovascular development [10].
We found that DAPT-treated 18 hpf embryos contained 55% more GFP-positive endothelial
cells compared to DMSO-treated embryos (Suppl. Fig. 3). Therefore, Notch signaling appears
to negatively regulate the number of endothelial cells throughout the entire embryo. Consistent
with our findings, all known notch genes and two delta genes are expressed in the zebrafish
gastrula (Suppl. Fig. 4).
Previous studies have demonstrated that Notch signaling is required at multiple time points to
regulate various aspects of vascular development [11–15]. To define the time frame in which
Notch signaling modulates the number of endothelial cells, embryos were treated with DAPT
during distinct stages of development. Embryos treated from 6 to 10 hpf and from 14 to 18 hpf
did not exhibit obvious changes in the number of endothelial cells. In contrast, embryos
incubated with DAPT from 10 to 14 hpf displayed a similar increase in the number of
endothelial cells as those continuously treated from 6 to 18 hpf (Suppl. Fig. 5 and data not
shown). Interestingly, decreased Notch activity at this stage did not inhibit the differentiation
of arterial endothelial cells (as determined by EphrinB2a expression), suggesting that the
function of Notch signaling in limiting the number of the endothelial cells can be separated
from the previously reported function in promoting arterial endothelial cell fate.
In order to test whether increased Notch activity might cause the opposite effect on the number
of endothelial cells, Tg(hsp70l:Gal4)kca4;Tg(UAS:myc-notch:intra)kca3 [16] embryos were
heat-shocked at shield stage (6 hpf) to induce the expression of the intracellular domain of
Notch (NICD). Embryos expressing the NICD (detected by presence of the myc epitope)
exhibited a significant decrease in the number of endothelial cells compared to non-heat-
shocked control siblings (Fig. 1C). An average of 4.42 (s=1.09) endothelial nuclei were present
in the control embryos (n=31), while an average of 3.14 (s=0.80) endothelial nuclei were found
in the embryos expressing NICD (n=28), representing a 29% loss in endothelial cell number
(ANOVA, p<10−5; Fig. 1D). Therefore, increased Notch activity leads to a reduction in the
number of endothelial cells. Taken together, our results show that Notch signaling negatively
regulates the number of the endothelial cells during early zebrafish development.
To determine whether the observed gain of endothelial cells in embryos with decreased Notch
activity was caused by changes in cell proliferation or cell death, we measured these events in
DAPT- and DMSO-treated embryos at 12, 14, and 16 hpf. Neither BrdU incorporation nor
staining with the mitotic marker phospho-HistoneH3 showed any discernable differences in
cell proliferation within the endothelial cells between DAPT- and DMSO-treated embryos
(Suppl. Fig. 6). In addition, Acridine Orange and anti-Caspase3/8 staining did not reveal any
differences in cell death between the two groups (data not shown), suggesting that these
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processes are not likely to be the major cause for the increased number of endothelial cells in
embryos with decreased Notch activity.
We then speculated that the excess endothelial cells might have resulted from the expansion
of the endothelial progenitor population within the mesoderm, potentially at the expense of
other related lineages. To test this hypothesis, we investigated the effect of modulated Notch
signaling on the hematopoietic lineage, which develops in close spatiotemporal proximity to
the endothelial lineage during embryogenesis [2,17]. In DAPT-treated embryos, the expression
level of hematopoietic markers, including gata1 [18], ikaros [19], and draculin [20], drastically
decreased in comparison to DMSO-treated embryos (Fig. 2A and data not shown). The reduced
expression of these in situ markers appears to be specific to the hematopoietic lineage, since
the non-hematopoietic markers krox20 [21] and otx1 [22] (Fig. 2A) showed equivalent levels
of expression.
To confirm that the reduced expression of hematopoietic lineage markers detected by in situ
hybridization was the result of a decreased number of hematopoietic cells, we used Tg
(gata1:EGFP)la781 [23] embryos to count the number of GFP-positive erythrocytes in DAPT-
and DMSO-treated embryos. Since DAPT-treated embryos exhibited a drastic increase in the
number of endothelial cells in their posterior half where the majority of hematopoietic cells
are erythrocytes, counting the number of erythrocytes serves as a simple surrogate measure to
identify any discernable changes in the number of hematopoietic cells. Compared to an average
of 8.07 (s=2.38) erythrocyte nuclei per section in DMSO-treated embryos (n=27), embryos
treated with DAPT (n=19) had an average of 4.89 (s=2.15) erythrocyte nuclei (Fig. 2B),
approximately a 39% decrease (ANOVA, p<10−4; Fig. 2C). Conversely, embryos over-
expressing the NICD exhibited a significant increase in the number of erythrocytes compared
to control siblings (ANOVA, p<10−6; Fig. 2D–E).
Unlike the hematopoietic lineage, no discernable changes in the number of somitic (detected
with S58 and F59 antibodies [24]) or pronephric duct (Tg(pax2a:GFP)e1 [25]) cells were
detected in embryos treated with DAPT, suggesting that the contribution of progenitors giving
rise to other non-axial mesodermal lineages was negligible (Suppl. Fig. 7 and data not shown).
To further characterize the effects of perturbed Notch signaling on the endothelial and
hematopoietic lineages, we treated Tg(kdrl:Ras-mCherry)s896;Tg(gata1: EGFP)la781 embryos
with DAPT. Interestingly, the embryos exhibited a concomitant loss of erythrocytes and gain
of endothelial cells (Fig. 3A), suggesting that Notch signaling might regulate the number of
the endothelial and hematopoietic cells during the same developmental stages. To investigate
the possibility of a transformation of hematopoietic progenitors into endothelial progenitors at
early stages in embryos with compromised Notch signaling, homozygous bloodless (bds)
mutant embryos were treated with DAPT. The bds mutation obliterates all primitive
hematopoietic cells via lineage-specific apoptosis, without impacting the endothelial lineage
[26]. Thus, if hematopoietic progenitors within the mesoderm are transformed to endothelial
progenitors as a result of decreased Notch activity, there should be no discernable change in
the number of endothelial cells in the bds mutant embryos.
In DAPT-treated bds mutant embryos (n=20), an average of 6.05 (s=1.32) endothelial nuclei
were present per section, while DMSO-treated bds mutant embryos (n=22) and DAPT-treated
phenotypic wild-type siblings (n=24) contained an average of 5.95 (s=1.13) and 8.04 (s=2.36)
endothelial nuclei, respectively (Fig. 3B). Thus, we found no significant difference in the
number of endothelial cells in bds mutant embryos treated with DAPT (ANOVA, p<0.80; Fig.
3C). These data suggest that decreased Notch activity causes a transformation of hematopoietic
progenitors to endothelial progenitors, and that Notch signaling might function as a cell fate
switch between the two lineages.
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To further test the function of Notch signaling as a cell fate switch between the endothelial and
hematopoietic lineages, lineage tracing experiments were performed [2]. Single-cell stage
embryos were injected with DMNB-caged fluorescein conjugated dextran. At shield stage,
approximately ten cells within the ventral margin of the zebrafish gastrula, which
predominantly generate the primitive hematopoietic lineage, were uncaged with UV
irradiation. Subsequently, embryos were treated with DAPT or DMSO (Fig. 4A). If there is a
direct transformation of hematopoietic progenitors to endothelial progenitors as a result of
decreased Notch activity, the increased contribution to the endothelial lineage from the ventral
margin should be detected. As the cells from the ventral marginal zone rarely contribute to the
endothelial lineage [2], an average of 0.16 (s=0.37) endothelial cells per focal plane contained
uncaged fluorescein in DMSO-treated embryos (n=18) (Fig. 4B and C). In contrast, in DAPT-
treated embryos (n=13), an average of 1.61 (s=1.01) endothelial cells per focal plane showed
co-localization with uncaged fluorescein (Fig. 4B and C). These data support a model in which
hematopoietic progenitors within the ventral marginal zone of the zebrafish gastrula are
transformed to endothelial progenitors upon the inhibition of Notch signaling, which eventually
leads to an increased number of endothelial cells (Fig. 4D).
Considering the existence of common progenitors for the endothelial and hematopoietic
lineages in zebrafish [2], it is tempting to speculate that Notch signaling might function as a
bipotential cell fate switch for the two lineages by regulating the hemangioblasts, resulting in
descendents preferentially adopting an endothelial fate. However, the observed magnitude of
the increase in endothelial cells after inhibition of Notch signaling suggests that while such an
event is possible, it probably does not account for the full effect.
Conclusion
Our experiments provide evidence that Notch signaling negatively regulates the number of
endothelial cells by modulating the specification of endothelial progenitors. This novel
function of Notch signaling can be separated from a previously known function in promoting
the differentiation of arterial endothelial cells at later stages of development. In addition, our
data indicate that the effect of Notch signaling on endothelial cell number is the result of the
direct transformation of hematopoietic progenitors into endothelial progenitors. Taken
together, our results suggest that Notch signaling functions as a cell fate switch between the
endothelial and the hematopoietic lineages within the nascent mesoderm.
Experimental Procedures
Zebrafish husbandry, morpholino injection, chemical and heat-shock treatments
Zebrafish (Danio rerio) embryos were obtained from the UNC-CH Zebrafish Aquaculture Core
Facility and raised as previously described [26]. The following mutant and transgenic lines
were used: bdsa75 [26], cass4 [10], mibta56b [7], Tg(gata1:EGFP)la781 [23], Tg
(hsp70l:Gal4)kca4 [16], Tg(fli1a:nGFP)y7 [8], Tg(kdrl:EGFP)s843 [5], Tg(kdrl:Ras-
mCherry)s896 [9], Tg(pax2a:GFP)e1 [24], and Tg(UAS:myc-notch:intra)kca3 [16].
Homozygous mibta56a embryos were identified by PCR, and homozygous bdsa75 embryos were
identified based on the lack of ikaros expression by RT-PCR.
Embryos were treated with 100μM DAPT (CalBiochem) as previously described[6]. Embryos
were treated from 6 to 18 hours post-fertilization (hpf), unless noted otherwise, and
subsequently fixed in 4% paraformaldehyde (PFA) overnight prior to processing. To induce
ectopic Notch signaling, embryos from crosses between Tg(hsp70l:Gal4)kca4/+ and Tg
(UAS:myc-notch:intra)kca3/+;Tg(kdrl:EGFP)s843 individuals were raised at 28°C until shield
stage (6 hpf), and subjected to treatment at 40°C for 30 minutes. Bright-field microscopy and
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myoD [28] in situ hybridization were used to verify that the treated embryos exhibited no
developmentally delays compared to the control embryos (Suppl. Fig. 8).
Immunohistochemistry, in situ hybridization, and BrdU Incorporation
Immunohistochemistry and whole mount in situ hybridization were performed as previously
described [5]. The antibodies and riboprobes used can be found in Supplemental Data.
Polymerized actin was visualized by phalloidin (Molecular Probes) at 1:300 and nuclei were
visualized with TOPRO (Molecular Probes) at 1:10,000. For immunohistochemistry,
processed samples were mounted in Vectashield (Vector Laboratories) and the images were
acquired using a Zeiss 510 Meta confocal microscope (Michael Hooker Microscopy Facility,
UNC-CH) or a Zeiss LSM5 Pascal confocal microscope. For whole mount in situ hybridization,
embryos were mounted in benzylbenzoate:benzyl alcohol and documented with Zeiss
Axiocam.
For BrdU incorporation, homozygous Tg(kdrl:EGFP)s843 embryos were treated with DAPT
or DMSO from 10 to 18 hpf and also incubated in 10mM BrdU in 5% DMSO from 14 hpf to
16 hpf. At 18 hpf, embryos were fixed in 4% PFA overnight and then incubated in rat
monoclonal anti-BrdU followed by anti-rat Alexa Fluor 568.
Lineage tracing
Lineage tracing was performed as previously described [2]. Briefly, Tg(kdrl:EGFP)s843
embryos were injected with 4.6nl of 0.2% DNMB-caged, biotinylated, lysine fixable
fluorescein dextran (Molecular probes) in 0.2M KCl and allowed to develop until shield stage
(6 hpf). The cells located in the first three vegetal tiers of the ventral margin were activated
using pulses from a 360 nm laser focused through a 20× objective. Embryos were then treated
with DAPT or DMSO and fixed at 18 hpf. To detect activated fluorescein and distinguish it
from GFP, embryos were incubated in biotinylated rabbit IgG anti-FITC antibody followed by
Alexa Fluor 568 Streptavidin (Molecular Probes).
Analysis of Variance (ANOVA)
The data were analyzed with one-way ANOVA for the effect of different treatments on the
number of cells of interest. A p-value smaller than 0.01 was regarded as significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Notch signaling negatively regulates the number of endothelial cells during zebrafish
development
(A) Transverse sections of 18 hpf embryos, DMSO- or DAPT-treated, visualized for TOPRO
(white), kdrl:GFP (green), and phalloidin (red). (B) Quantification of endothelial nuclei per
focal plane in DMSO-treated (n=30) or DAPT-treated (n=44) embryos. (C) Transverse sections
of 18 hpf phenotypic wild-type siblings and Tg(hsp70l:Gal4)kca4;Tg(UAS:myc-NICD)kca3
embryos visualized for TOPRO (white), kdrl:GFP (green), and c-Myc as a surrogate measure
for NICD expression (red). (D) Quantification of endothelial nuclei per focal plane in
phenotypic wild-type (n=31) and NICD over-expressing (n=28) embryos. Embryos treated
with DAPT contained 6.66 (s=2.42) endothelial nuclei per section, while those treated with
DMSO had 4.03 (s=1.27) endothelial nuclei (ANOVA, p<10−6). Conversely, embryos over-
expressing the NICD contained 3.14 (s=0.80) endothelial nuclei, compared to 4.42 (s=1.09)
nuclei per section in phenotypic wild-type siblings (ANOVA, p<10−5), suggesting that Notch
signaling negatively regulates endothelial cell number.
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Fig. 2. Notch signaling positively regulates the number of hematopoietic cells during zebrafish
development
(A) Whole mount RNA in situ hybridization showing the expression of gata1 in 18 hpf DMSO-
treated or DAPT-treated embryos. Two additional markers, krox20 and otx1, which label the
hindbrain and neuroectoderm, respectively, were used as positive controls. Notice the reduced
expression of gata1 in DAPT-treated embryos (black arrow). (B) Transverse sections of 18
hpf DMSO- or DAPT-treated embryos visualized for TOPRO (white), gata1:GFP (green), and
phalloidin (red). (C) Quantification of the hematopoietic nuclei per focal plane in DMSO-
treated (n=27) or DAPT-treated (n=19) embryos. (D) Transverse sections of 18 hpf phenotypic
wild-type siblings and Tg(hsp70l:Gal4)kca4;Tg(UAS:myc-NICD)kca3 embryos visualized for
TOPRO (white), gata1:GFP (green), and c-Myc as a surrogate measure for NICD expression
(red). (E) Quantification of the hematopoietic nuclei per focal plane in phenotypic wild-type
siblings (n=28) and NICD over-expressing embryos (n=23). DAPT-treated embryos contained
4.89 (s=2.15) erythrocyte nuclei compared to 8.07 (s=2.38) in DMSO-treated embryos
(ANOVA, p<10−4). Conversely, embryos over-expressing the NICD contained 9.89 (s=2.53)
erythrocyte nuclei, compared to 6.72 (s=1.43) nuclei per section in phenotypic wild-type
siblings (ANOVA, p<10−6), indicating that Notch signaling positively modulates the number
of hematopoietic cells.
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Fig. 3. Reduced Notch activity causes an increase of endothelial cells at the expense of hematopoietic
cells
(A) Transverse sections of 18 hpf DMSO- or DAPT-treated embryos, visualized for TOPRO
(white), kdrl:mCherry (red), and gata1:GFP (green). DAPT-treated embryos exhibited a
concomitant gain of endothelial cells and loss of hematopoietic cells. (B) Transverse sections
of 20 hpf DMSO- or DAPT-treated phenotypic bloodless (bds) mutant embryos, visualized for
TOPRO (white), kdrl:GFP (green), and phalloidin (red). (C) Quantification of the number of
endothelial nuclei per focal plane in DMSO-treated bds (n=22), DAPT-treated bds (n=20), and
DAPT-treated wild-type sibling (n=24) embryos. DAPT treatment in embryos lacking
primitive hematopoietic cells (bds + DAPT) did not result in a change in the number of
endothelial cells, suggesting that the ectopic endothelial cells observed in DAPT-treated wild-
type embryos might have originated from cells that normally produce hematopoietic cells.
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Fig. 4. Notch signaling functions as a cell fate switch between the endothelial and the hematopoietic
lineages in the nascent mesoderm
(A) Experimental scheme of the lineage tracing experiment. Single-cell stage embryos were
injected with DMNB-caged fluorescein conjugated dextran. At shield stage, ten cells within
the ventral margin, which predominantly gives rise to hematopoietic cells, were uncaged with
UV irradiation. Subsequently, embryos were treated with either DMSO or DAPT until 18 hpf.
(B) Transverse sections of 18 hpf embryos treated with DMSO or DAPT after uncaging,
visualized for TOPRO (white), kdrl:GFP (green), and uncaged fluorescein (red). White
arrowheads point to endothelial cells that contain uncaged fluorescein in DAPT-treated
embryos. (C) Quantification of the number of endothelial nuclei with uncaged fluorescein per
focal plane in embryos treated with DMSO (n=18) or DAPT (n=13). Embryos treated with
DAPT contained 1.61 (s=1.01) fluorescein-positive endothelial cells, compared to 0.16
(s=0.37) in DMSO-treated embryos. (D) Our proposed model: Notch signaling negatively
regulates endothelial cell number by limiting the mesodermal cells that can differentiate into
endothelial progenitors. Attenuated Notch activity causes mesodermal cells with hematopoietic
potential to differentiate into endothelial progenitors, thus increasing the number of endothelial
cells.
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